These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. CER818: A Highly Specific and Sensitive HPV L1 High-Risk Serological Lateral Flow Rapid Test for Early Detection of Cervical Cancer and Its Precursor Lesions. Bräutigam K; Meier S; Köster F; Rody A; Hilfrich R Infect Dis Obstet Gynecol; 2024; 2024():6651272. PubMed ID: 39108464 [No Abstract] [Full Text] [Related]
46. The Role of Scientific Research in Human Papillomavirus Vaccine Discussions on Twitter: Social Network Analysis. Jessiman-Perreault G; Boucher JC; Kim SY; Frenette N; Badami A; Smith HM; Allen Scott LK JMIR Infodemiology; 2024 May; 4():e50551. PubMed ID: 38722678 [TBL] [Abstract][Full Text] [Related]
47. Colposcopy in the Primary Health Care: A Scoping Review. Benites-Zapata VA; Hernandez-Bustamante EA; Acuña-Chávez LM; Escudero-Gaytan CP; Ulloque-Badaracco JR; Alarcón-Braga EA; Venegas G; Herrera-Añazco P J Prim Care Community Health; 2023; 14():21501319231198942. PubMed ID: 37740513 [TBL] [Abstract][Full Text] [Related]
48. Living the best of both worlds: A personal scientific journey. Tsongalis GJ FASEB Bioadv; 2022 Feb; 4(2):95-101. PubMed ID: 35141473 [TBL] [Abstract][Full Text] [Related]
49. Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis. Cho HW; Shim SR; Lee JK; Hong JH J Gynecol Oncol; 2022 Jan; 33(1):e4. PubMed ID: 34783207 [TBL] [Abstract][Full Text] [Related]
50. HPV, vaccines, and cervical cancer in a low- and middle-income country. Petersen LM; Fenton JM; Kennedy LS; LaRochelle EPM; Bejarano S; Tsongalis GJ Curr Probl Cancer; 2020 Dec; 44(6):100605. PubMed ID: 32507365 [TBL] [Abstract][Full Text] [Related]
51. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555 [TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus: science and technologies for the elimination of cervical cancer. Bosch FX Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205 [TBL] [Abstract][Full Text] [Related]
53. Screening for Human Papillomavirus in a Low- and Middle-Income Country. Atkinson AE; Mandujano CAM; Bejarano S; Kennedy LS; Tsongalis GJ J Glob Oncol; 2019 May; 5():JGO1800233. PubMed ID: 31050922 [TBL] [Abstract][Full Text] [Related]
54. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program. Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451 [TBL] [Abstract][Full Text] [Related]
55. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand. Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913 [TBL] [Abstract][Full Text] [Related]
56. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method]. Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331 [TBL] [Abstract][Full Text] [Related]